U.S. gives AstraZeneca $1.2 billion to fund Oxford University coronavirus vaccine, securing 300 million doses for country from October

British drugmaker AstraZeneca has received more than $1 billion in U.S. funding to accelerate the development of Oxford University’s coronavirus vaccine candidate.